ABP
Price
$0.23
Change
+$0.01 (+4.55%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
13.56M
FBIO
Price
$1.83
Change
+$0.03 (+1.67%)
Updated
Jun 26, 04:55 PM (EDT)
Capitalization
54.7M
Interact to see
Advertisement

ABP vs FBIO

Header iconABP vs FBIO Comparison
Open Charts ABP vs FBIOBanner chart's image
Abpro Holdings
Price$0.23
Change+$0.01 (+4.55%)
Volume$59.65K
Capitalization13.56M
Fortress Biotech
Price$1.83
Change+$0.03 (+1.67%)
Volume$574
Capitalization54.7M
ABP vs FBIO Comparison Chart in %
Loading...
ABP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABP vs. FBIO commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABP is a StrongBuy and FBIO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (ABP: $0.22 vs. FBIO: $1.85)
Brand notoriety: ABP and FBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABP: 37% vs. FBIO: 73%
Market capitalization -- ABP: $13.56M vs. FBIO: $54.7M
ABP [@Biotechnology] is valued at $13.56M. FBIO’s [@Biotechnology] market capitalization is $54.7M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABP’s FA Score shows that 1 FA rating(s) are green whileFBIO’s FA Score has 1 green FA rating(s).

  • ABP’s FA Score: 1 green, 4 red.
  • FBIO’s FA Score: 1 green, 4 red.
According to our system of comparison, both ABP and FBIO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABP’s TA Score shows that 2 TA indicator(s) are bullish while FBIO’s TA Score has 5 bullish TA indicator(s).

  • ABP’s TA Score: 2 bullish, 3 bearish.
  • FBIO’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, FBIO is a better buy in the short-term than ABP.

Price Growth

ABP (@Biotechnology) experienced а +6.70% price change this week, while FBIO (@Biotechnology) price change was +2.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.59%. For the same industry, the average monthly price growth was +34.25%, and the average quarterly price growth was +14.95%.

Reported Earning Dates

ABP is expected to report earnings on Apr 15, 2025.

FBIO is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Biotechnology (+3.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FBIO($54.7M) has a higher market cap than ABP($13.6M). FBIO YTD gains are higher at: -8.642 vs. ABP (-87.542). ABP has higher annual earnings (EBITDA): -10.08M vs. FBIO (-89.64M). FBIO has more cash in the bank: 91.3M vs. ABP (1.26M). ABP has less debt than FBIO: ABP (3.25M) vs FBIO (74.2M). FBIO has higher revenues than ABP: FBIO (57.8M) vs ABP (183K).
ABPFBIOABP / FBIO
Capitalization13.6M54.7M25%
EBITDA-10.08M-89.64M11%
Gain YTD-87.542-8.6421,013%
P/E RatioN/AN/A-
Revenue183K57.8M0%
Total Cash1.26M91.3M1%
Total Debt3.25M74.2M4%
FUNDAMENTALS RATINGS
FBIO: Fundamental Ratings
FBIO
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABPFBIO
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
50%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
19%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
43%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
50%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 17 days ago
48%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
73%
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ABP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MAIA1.740.06
+3.57%
MAIA Biotechnology
ZION51.401.27
+2.53%
Zions Bancorporation NA
GNTY43.280.83
+1.96%
Guaranty Bancshares
LMT457.90-2.30
-0.50%
Lockheed Martin Corp
LMAT82.40-2.14
-2.53%
LeMaitre Vascular

ABP and

Correlation & Price change

A.I.dvisor tells us that ABP and NGNE have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ABP and NGNE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABP
1D Price
Change %
ABP100%
+2.76%
NGNE - ABP
33%
Poorly correlated
-1.84%
FBIO - ABP
30%
Poorly correlated
+2.78%
QSI - ABP
25%
Poorly correlated
+1.49%
SCPH - ABP
24%
Poorly correlated
+0.25%
MNKD - ABP
24%
Poorly correlated
-2.08%
More